Moolec Science (MLEC) Total Liabilities (2022 - 2026)
Moolec Science (MLEC) reported Total Liabilities of $93.4 million for Q1 2026, up 5.88% sequentially from $88.2 million in Q4 2025.
Moolec Science (MLEC) Total Liabilities (2022 - 2026) Analysis & Trends
Moolec Science (MLEC) has 5 years of Total Liabilities data on file, last reported at $93.4 million in Q1 2026.
- For the quarter ending Q1 2026, Total Liabilities changed N/A year-over-year to $93.4 million; the trailing twelve-month figure through Mar 2026 stood at $93.4 million (changed N/A YoY), and the FY2025 full-year result was $289.1 million, down 58.69% from the prior year.
- Total Liabilities advanced to $93.4 million in Q1 2026, from $88.2 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $699.8 million in Q2 2024 to a low of $4.1 million in Q2 2022.
- A 5-year average of $100.6 million and a median of $19.3 million in 2024 frame the typical range for Total Liabilities.
- Across the five-year window, Total Liabilities jumped 4918.41% in 2024 and slumped 58.69% in 2025, its largest moves.
- Tracing MLEC's Total Liabilities over 5 years: stood at $11.3 million in 2022, then advanced by 29.78% to $14.6 million in 2023, then soared by 95.29% to $28.6 million in 2024, then surged by 208.59% to $88.2 million in 2025, then grew by 5.88% to $93.4 million in 2026.
- Business Quant data shows MLEC's Total Liabilities at $93.4 million in Q1 2026, $88.2 million in Q4 2025, and $289.1 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | 177.22 Mn |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | 19.51 Mn |
| 4 | BeOne Medicines | 472.03 Bn | 467.24 Bn | 1.35 Bn | 3.79 Bn |
| 5 | Vertex Pharmaceuticals | 122.09 Bn | 114.84 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 70.01 Bn | 61.26 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 55.99 Bn | 50.80 Bn | 1.41 Bn | 1.62 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 4.05 Bn |
| 10 | Moolec Science | 5.35 Bn | 5.35 Bn | - | 93.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 93.40 Mn |
| Dec 31, 2025 | 88.21 Mn |
| Jun 30, 2025 | 289.10 Mn |
| Dec 31, 2024 | 28.58 Mn |
| Sep 30, 2024 | 26.87 Mn |
| Jun 30, 2024 | 699.84 Mn |
| Mar 31, 2024 | 19.31 Mn |
| Dec 31, 2023 | 14.64 Mn |
| Sep 30, 2023 | 13.60 Mn |
| Jun 30, 2023 | 13.95 Mn |
| Mar 31, 2023 | 4.51 Mn |
| Dec 31, 2022 | 11.28 Mn |
| Jun 30, 2022 | 4.09 Mn |